Type / Class
Equity / Common Stock, $0.00001 par value
Shares outstanding
19.1M
Number of holders
32
Total 13F shares, excl. options
3.64M
Shares change
-642K
Total reported value, excl. options
$19.8M
Value change
-$3.15M
Put/Call ratio
0.06
Number of buys
20
Number of sells
-14
Price
$5.44

Significant Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) as of Q1 2024

42 filings reported holding NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value as of Q1 2024.
enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3.64M shares of 19.1M outstanding shares and own 19.03% of the company stock.
Largest 10 shareholders include KINGDON CAPITAL MANAGEMENT, L.L.C. (654K shares), PERCEPTIVE ADVISORS LLC (623K shares), VANGUARD GROUP INC (574K shares), Nantahala Capital Management, LLC (496K shares), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) (226K shares), ADAR1 Capital Management, LLC (202K shares), Velan Capital Investment Management LP (172K shares), GEODE CAPITAL MANAGEMENT, LLC (137K shares), MORGAN STANLEY (97.6K shares), and CITADEL ADVISORS LLC (45.6K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.